Sarrió, DavidMartínez-Val, JeannetteMolina Crespo, ÁngelaSánchez Piñón, LauraMoreno-Bueno, Gema2024-01-242024-01-242021Sarrió, D., Martínez-Val, J., Molina-Crespo, Á., Sánchez, L., & Moreno-Bueno, G. (2021). The multifaceted roles of gasdermins in cancer biology and oncologic therapies. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1876(2), 1886351879-2561http://hdl.handle.net/10347/31975The involvement of the Gasdermin (GSDM) protein family in cancer and other pathologies is one of the hottest topics in biomedical research. There are six GSDMs in humans (GSDMA, B, C, D, GSDME/DFNA5 and PJVK/ DFNB59) and, except PJVK, they can trigger cell death mostly by pyroptosis (a form of lytic and proinflammatory cell death) but also other mechanisms. The exact role of GSDMs in cancer is intricate, since depending on the biological context, these proteins have diverse cell-death dependent and independent functions, exhibit either pro-tumor or anti-tumor functions, and promote either sensitization or resistance to oncologic treatments. In this review we provide a comprehensive overview on the multifaceted roles of the GSDMs in cancer, and we critically discuss the possibilities of exploiting GSDM functions as determinants of anti-cancer treatment and as novel therapeutic targets, with special emphasis on innovative GSDM-directed nano-therapies. Finally, we discuss the issues to be resolved before GSDM-mediated oncologic therapies became a reality at the clinical level.eng© 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND licensehttp://creativecommons.org/licenses/by-nc-nd/4.0/GasderminPyroptosisCancer cell deathCancer treatmentInflammationjournal article10.1016/j.bbcan.2021.188635open access